CLASSYS Inc. (KOSDAQ:214150)
57,900
-1,800 (-3.02%)
At close: Jan 19, 2026
CLASSYS Market Cap
CLASSYS has a market cap or net worth of 3.78 trillion as of January 16, 2026. Its market cap has increased by 20.06% in one year.
Market Cap
3.78T
Enterprise Value
3.70T
Revenue
317.80B
Ranking
n/a
PE Ratio
32.34
Stock Price
57,900.00
Market Cap Chart
Since December 13, 2017, CLASSYS's market cap has increased from 279.08B to 3.78T, an increase of 1,255.44%. That is a compound annual growth rate of 37.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 3.78T | 6.24% |
| Dec 30, 2025 | 3.56T | 14.07% |
| Dec 30, 2024 | 3.12T | 28.96% |
| Dec 28, 2023 | 2.42T | 104.22% |
| Dec 29, 2022 | 1.19T | -2.59% |
| Dec 30, 2021 | 1.22T | 22.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.18T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.83T |
| Sam Chun Dang Pharm. | 6.43T |